Zydus Lifesciences Limited Buyback
Zydus Lifesciences Buyback 2024
Tender Offer
₹1,005.00
Buyback price per share22 Feb, 2024
Last Date to buy shares23 Feb, 2024
Record Date29 Feb, 2024
Offer Opens06 Mar, 2024
Offer Closes06 Mar, 2024
Last Date for Tender Forms13 Mar, 2024
Finalisation of Buyback Acceptance14 Mar, 2024
Last Date for settlement of bids26 Mar, 2024
Last Date for Extinguishment of SharesAbout Zydus Lifesciences Limited Buyback Company
Zydus Lifesciences Limited is a leading Indian Pharmaceutical company that offers healthcare services globally.
The company manufactures formulations, APIs, vaccines, biosimilars, complex products (transdermals, topical etc.), animal health products as well as wellness products.
Zydus Lifesciences Limited has more than 30 manufacturing plants worldwide including India, Germany, Brazil & USA. Zydus Lifesciences Limited is the fourth largest pharmaceutical company in India. Zydus Lifesciences was formerly known as Cadila Healthcare Limited.
Zydus Lifesciences Limited Buyback Details
- Security Name Zydus Lifesciences Limited
- Buyback Price ₹1,005.00
- Face Valuet ₹1.00
- Listing at Group BSE, NSE
- Lead Manager ICICI Securities Limited
- Issue Size 5,970,149 (0.59 % of Total number of equity Shares)
- Buyback Docs Letter Of Offer
Zydus Lifesciences Limited Buyback Ratio
| Categoryy | Entitlement Ratio of Buyback | Shares Offered |
|---|---|---|
| Reserved Category for Small Shareholders | 6/67 | 895523 |
| General Category for all other Eligible Shareholders | 2/395 | 5074626 |
Zydus Lifesciences Limited Buyback Company Financials
| 31-Mar-23 | 31-Mar-22 | 31-Mar-21 | |
|---|---|---|---|
| Profit After Tax | 1,529.20 | 857.90 | 1,476.20 |
| Reserves And Surplus | 1,801.75 | -- | -- |
| Net Worth | 17,515.80 | 16,999.60 | 12,992.30 |
| Total Assets | -- | -- | -- |
| Total Borrowing | 1,163.20 | 4,196.00 | 4,583.50 |
| Total Revenue | 9,553.50 | 8,160.60 | 7,869.30 |
How to Participate in Zydus Lifesciences Limited Buyback?
Calculation of Investment in Zydus Lifesciences Limited Buyback Buyback 2026
* No. of shares stands to change according to the closing price on the record date
* For simplicity, we have considered the price on date Feb 9, 2024
Expected Profit from the Zydus Lifesciences Limited Buyback on the bases of acceptance Ratio:
| Acceptance Ratio | Amount Invested in Buyback | No. of Shares Buyback | Buyback Profit | Profit% |
|---|---|---|---|---|
| 33% | ₹159,572.14 | 65 | 13204 | 8.27% |
| 50% | ₹159,572.14 | 99 | 20111 | 12.60% |
| 75% | ₹159,572.14 | 149 | 30269 | 18.97% |
| 100% | ₹159,572.14 | 199 | 40426 | 25.33% |
Amount Invested in Buyback: ₹159,572.14
Zydus Lifesciences Limited Buyback - Necessity of the Objective
The Buyback will help the company to distribute a part of the surplus cash to its shareholders holding equity shares thereby, optimizing returns to the shareholders and enhancing the overall shareholders' value in the longer term, and improving the return on equity.
Contact Details
Zydus Lifesciences Limited Buyback
Zydus Corporate Park, Scheme No. 63, Khoraj (Gandhinagar), 536, Sarkhej-Gandhinagar Hwy, Near Vaishnodevi Circle, Ahmedabad 382481
+91-79-71800000
dhavalsoni@zyduslife.com
Registrar Contact Details
Link Intime India Private Ltd
zyduslife.buyback2024@linkintime.co.in
+91-22-4918 6270